Selective laser photocoagulation versus serial amniodrainage for the treatment of twin-twin transfusion syndrome

A cost-effectiveness analysis

A. O. Odibo, Aaron Caughey, W. Grobman, D. M. Stamilio, Y. Ville

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objective: To compare the cost-effectiveness of selective laser photocoagulation (SLP) with serial amniodrainage (AD) in the treatment of twin-to-twin transfusion syndrome (TTTS). Study design: Using decision-analysis modeling, we compared the cost-effectiveness of using laser photocoagulation with AD for the treatment of TTTS. The analysis was carried out from a societal perspective using a theoretical cohort of 1000 women with TTTS. Costs included the costs of procedures, perinatal complications from TTTS and of resources used for raising a child with cerebral palsy (CP) following TTTS. One-way, multiway and probabilistic (Monte Carlo) sensitivity analyses were carried out for all model variables. The main outcome measures were: cost per quality-adjusted life years (QALYs) gained from treating TTTS. Result: On the basis of the available data, the decision model favors SLP as the most cost-effective treatment option compared with AD. Using the theoretical cohort, laser photocoagulation will result in an overall perinatal survival of 59.3% compared with 51.5% for AD. The frequency of children with CP after laser would be 8.5% compared with 15.4% after AD. Sensitivity analyses showed the model to be robust over a wide range of values for the variables, except when the overall survival associated with AD is >62%. Above that survival rate, AD was the more cost-effective therapy. Conclusion: Under a wide range of circumstances, the most cost-effective therapy for TTTS is SLP.

Original languageEnglish (US)
Pages (from-to)543-547
Number of pages5
JournalJournal of Perinatology
Volume29
Issue number8
DOIs
StatePublished - 2009
Externally publishedYes

Fingerprint

Fetofetal Transfusion
Light Coagulation
Cost-Benefit Analysis
Lasers
Costs and Cost Analysis
Decision Support Techniques
Cerebral Palsy
Therapeutics
Survival
Quality-Adjusted Life Years
Health Care Costs
Survival Rate
Outcome Assessment (Health Care)

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Pediatrics, Perinatology, and Child Health

Cite this

Selective laser photocoagulation versus serial amniodrainage for the treatment of twin-twin transfusion syndrome : A cost-effectiveness analysis. / Odibo, A. O.; Caughey, Aaron; Grobman, W.; Stamilio, D. M.; Ville, Y.

In: Journal of Perinatology, Vol. 29, No. 8, 2009, p. 543-547.

Research output: Contribution to journalArticle

@article{3ecee084a63340099c9b376b14a1c200,
title = "Selective laser photocoagulation versus serial amniodrainage for the treatment of twin-twin transfusion syndrome: A cost-effectiveness analysis",
abstract = "Objective: To compare the cost-effectiveness of selective laser photocoagulation (SLP) with serial amniodrainage (AD) in the treatment of twin-to-twin transfusion syndrome (TTTS). Study design: Using decision-analysis modeling, we compared the cost-effectiveness of using laser photocoagulation with AD for the treatment of TTTS. The analysis was carried out from a societal perspective using a theoretical cohort of 1000 women with TTTS. Costs included the costs of procedures, perinatal complications from TTTS and of resources used for raising a child with cerebral palsy (CP) following TTTS. One-way, multiway and probabilistic (Monte Carlo) sensitivity analyses were carried out for all model variables. The main outcome measures were: cost per quality-adjusted life years (QALYs) gained from treating TTTS. Result: On the basis of the available data, the decision model favors SLP as the most cost-effective treatment option compared with AD. Using the theoretical cohort, laser photocoagulation will result in an overall perinatal survival of 59.3{\%} compared with 51.5{\%} for AD. The frequency of children with CP after laser would be 8.5{\%} compared with 15.4{\%} after AD. Sensitivity analyses showed the model to be robust over a wide range of values for the variables, except when the overall survival associated with AD is >62{\%}. Above that survival rate, AD was the more cost-effective therapy. Conclusion: Under a wide range of circumstances, the most cost-effective therapy for TTTS is SLP.",
author = "Odibo, {A. O.} and Aaron Caughey and W. Grobman and Stamilio, {D. M.} and Y. Ville",
year = "2009",
doi = "10.1038/jp.2009.39",
language = "English (US)",
volume = "29",
pages = "543--547",
journal = "Journal of Perinatology",
issn = "0743-8346",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Selective laser photocoagulation versus serial amniodrainage for the treatment of twin-twin transfusion syndrome

T2 - A cost-effectiveness analysis

AU - Odibo, A. O.

AU - Caughey, Aaron

AU - Grobman, W.

AU - Stamilio, D. M.

AU - Ville, Y.

PY - 2009

Y1 - 2009

N2 - Objective: To compare the cost-effectiveness of selective laser photocoagulation (SLP) with serial amniodrainage (AD) in the treatment of twin-to-twin transfusion syndrome (TTTS). Study design: Using decision-analysis modeling, we compared the cost-effectiveness of using laser photocoagulation with AD for the treatment of TTTS. The analysis was carried out from a societal perspective using a theoretical cohort of 1000 women with TTTS. Costs included the costs of procedures, perinatal complications from TTTS and of resources used for raising a child with cerebral palsy (CP) following TTTS. One-way, multiway and probabilistic (Monte Carlo) sensitivity analyses were carried out for all model variables. The main outcome measures were: cost per quality-adjusted life years (QALYs) gained from treating TTTS. Result: On the basis of the available data, the decision model favors SLP as the most cost-effective treatment option compared with AD. Using the theoretical cohort, laser photocoagulation will result in an overall perinatal survival of 59.3% compared with 51.5% for AD. The frequency of children with CP after laser would be 8.5% compared with 15.4% after AD. Sensitivity analyses showed the model to be robust over a wide range of values for the variables, except when the overall survival associated with AD is >62%. Above that survival rate, AD was the more cost-effective therapy. Conclusion: Under a wide range of circumstances, the most cost-effective therapy for TTTS is SLP.

AB - Objective: To compare the cost-effectiveness of selective laser photocoagulation (SLP) with serial amniodrainage (AD) in the treatment of twin-to-twin transfusion syndrome (TTTS). Study design: Using decision-analysis modeling, we compared the cost-effectiveness of using laser photocoagulation with AD for the treatment of TTTS. The analysis was carried out from a societal perspective using a theoretical cohort of 1000 women with TTTS. Costs included the costs of procedures, perinatal complications from TTTS and of resources used for raising a child with cerebral palsy (CP) following TTTS. One-way, multiway and probabilistic (Monte Carlo) sensitivity analyses were carried out for all model variables. The main outcome measures were: cost per quality-adjusted life years (QALYs) gained from treating TTTS. Result: On the basis of the available data, the decision model favors SLP as the most cost-effective treatment option compared with AD. Using the theoretical cohort, laser photocoagulation will result in an overall perinatal survival of 59.3% compared with 51.5% for AD. The frequency of children with CP after laser would be 8.5% compared with 15.4% after AD. Sensitivity analyses showed the model to be robust over a wide range of values for the variables, except when the overall survival associated with AD is >62%. Above that survival rate, AD was the more cost-effective therapy. Conclusion: Under a wide range of circumstances, the most cost-effective therapy for TTTS is SLP.

UR - http://www.scopus.com/inward/record.url?scp=68349085775&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68349085775&partnerID=8YFLogxK

U2 - 10.1038/jp.2009.39

DO - 10.1038/jp.2009.39

M3 - Article

VL - 29

SP - 543

EP - 547

JO - Journal of Perinatology

JF - Journal of Perinatology

SN - 0743-8346

IS - 8

ER -